Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Invested Capital (2022 - 2025)

Atara Biotherapeutics (ATRA) has disclosed Return on Invested Capital for 4 consecutive years, with 0.73% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Invested Capital fell 203.0% year-over-year to 0.73%, compared with a TTM value of 0.73% through Sep 2025, down 203.0%, and an annual FY2024 reading of 0.75%, up 2089.0% over the prior year.
  • Return on Invested Capital was 0.73% for Q3 2025 at Atara Biotherapeutics, down from 0.18% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 13.44% in Q3 2023 and bottomed at 8.47% in Q2 2023.
  • Average Return on Invested Capital over 4 years is 0.81%, with a median of 0.48% recorded in 2025.
  • Peak annual rise in Return on Invested Capital hit 1018bps in 2024, while the deepest fall reached -1214bps in 2024.
  • Year by year, Return on Invested Capital stood at 1.58% in 2022, then soared by 332bps to 3.68% in 2023, then crashed by -79bps to 0.79% in 2024, then crashed by -193bps to 0.73% in 2025.
  • Business Quant data shows Return on Invested Capital for ATRA at 0.73% in Q3 2025, 0.18% in Q2 2025, and 0.18% in Q1 2025.